Orgotein in the treatment of plastic induration of the penis (Peyronie's disease).
Eighteen patients with Peyronie's disease have been treated with the anti-inflammatory metalloprotein Orgotein, which exhibits a pronounced superoxide dismutase activity. Only patients with severe symptoms were selected. The drug was injected monthly into the indurated areas of the penis. Marked improvement was noted, especially regarding the loss of pain on erection. Only one adverse reaction has occurred.
Primus
G
G
Department of Urology, LKH, Graz, Austria.
D000328:Adult; D000368:Aged; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008667:Metalloproteins / Q000627:therapeutic use*; D008875:Middle Aged; D010411:Penile Induration / Q000188:drug therapy*
D000894:Anti-Inflammatory Agents, Non-Steroidal; D008667:Metalloproteins; C005180:orgotein